CSL: The agreement will support lowering the prices of CSL therapies and reflects CSL's plan to invest $1.5 billion to expand its manufacturing capacity in Illinois, USA. CSL does not expect to be significantly affected in fiscal year 2027.

2026-09-01

CSL: The agreement will support lowering the prices of CSL therapies and reflects CSL's plan to invest $1.5 billion to expand its manufacturing capacity in Illinois, USA. CSL does not expect to be significantly affected in fiscal year 2027.